prostate cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria:;- 50 -70 years of age - PSA * 4.0 ng/mL and/or positive digital rectal examination - suspicious lesion (PIRADS 3 to 5) on diagnostic MR imaging examination - Signed MRI screening form (to search for metal device/foreign bodies/claustrophobia) - Signed IRB-approved informed consent form
Exclusion criteria
Exclusion criteria: - Patients unable to undergo MR imaging, including those with contra-indications - Contra-indications to MR-guided prostate biopsy - Impossibility to obtain a valid informed consent - History of psychiatric treatment or current psychiatric treatment as revealed by self report. - History of neurological treatment or current neurological treatment as revealed by self report. - History of endocrine treatment or current endocrine treatment as revealed by self report. - Claustrophobia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of our study is to measure individual stress reactivity by means of self-assessment and cortisol changes in patients during MR-guided prostate biopsy. | — |
Secondary
| Measure | Time frame |
|---|---|
| The subjective and physiological stress response while undergoing the diagnostic intervention will be associated to potential predictive markers in personality characteristics, habitual stress levels, coping abilities and stress-related brain connectivity patterns. Brain connectivity measures related to stress response, such as the interplay between the human salience and executive control networks [13], stress coping abilities, depression, anxiety, psychological burden and long term stress exposure may constitute vulnerability or resilience factors in relation to the peri-interventional stress response. | — |
Countries
Netherlands